Vaccinia Virus Late Transcription Is Activated in Vitro by Cellular Heterogeneous Nuclear Ribonucleoproteins

This publication has 45 references indexed in Scilit:

• Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication
  Proceedings of the National Academy of Sciences, 2001
• Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus
  The EMBO Journal, 2000
• A Vaccinia Virus Late Transcription Factor with Biochemical and Molecular Identity to a Human Cellular Protein
  Journal of Biological Chemistry, 1998
• RBM3, a novel human gene in Xp11.23 with a putative RNA-binding domain
  Human Molecular Genetics, 1995
• An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
  Journal of the American Society for Mass Spectrometry, 1994
• Two homologous genes, originated by duplication, encode the human hnRNP proteins A2 and A1
  Nucleic Acids Research, 1994
• hnRNP PROTEINS AND THE BIOGENESIS OF mRNA
  Annual Review of Biochemistry, 1993
• Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm
  Nature, 1992
• Role of DNA replication in vaccinia virus gene expression: A naked template is required for transcription of three late trans-activator genes
  Cell, 1990
• Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts.
  Proceedings of the National Academy of Sciences, 1989